Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol describes the method, materials, equipment and steps for bottom-up preparation of RNA and protein producing synthetic cells. The inner aqueous compartment of the synthetic cells contained the S30 bacterial lysate encapsulated within a lipid bilayer (i.e., stable liposomes), using a water-in-oil emulsion transfer method.

Abstract

The bottom-up assembly approach for construction of synthetic cells is an effective tool for isolating and investigating cellular processes in a cell mimicking environment. Furthermore, the development of cell-free expression systems has demonstrated the ability to reconstitute the protein production, transcription and translation processes (DNA→RNA→protein) in a controlled manner, harnessing synthetic biology. Here we describe a protocol for preparing a cell-free expression system, including the production of a potent bacterial lysate and encapsulating this lysate inside cholesterol-rich lipid-based giant unilamellar vesicles (GUVs) (i.e., stable liposomes), to form synthetic cells. The protocol describes the methods for preparing the components of the synthetic cells including the production of active bacterial lysates, followed by a detailed step-by-step preparation of the synthetic cells based on a water-in-oil emulsion transfer method. These facilitate the production of millions of synthetic cells in a simple and affordable manner with a high versatility for producing different types of proteins. The obtained synthetic cells can be used to investigate protein/RNA production and activity in an isolated environment, in directed evolution, and also as a controlled drug delivery platform for on-demand production of therapeutic proteins inside the body.

Introduction

Synthetic cells are artificial cell-like particles, mimicking one or multiple functions of a living cell, such as the ability to divide, form membrane interactions, and synthesize proteins based on a genetic code1,2,3. Synthetic cells that enclose cell-free protein synthesis (CFPS) systems possess high modularity due to their ability to produce various proteins and RNA sequences following alterations in the DNA template. Presenting an attractive alternative to the current approaches of protein production, CFPS systems are based on cell lysate, purified components, or syntheti....

Protocol

NOTE: Illustration of the complete synthetic cells’ production protocol is presented in Figure 1. According to the user’s needs, the protein expression (section 3.2) and synthetic cell formation (section 4) parts of the protocol can also be carried out independently (with some adaptations).

1. Preparation of S30-T7 lysate

  1. Streak plate the E. coli BL21(DE3) bacteria transformed with the T7 RNA polymerase expressing pAR1219 plasmid o.......

Representative Results

We present a protocol for the preparation of synthetic cells by encapsulating a S30-T7 CFPS system based on BL21 E. coli inside lipid vesicles. A schematic description of the preparation process that includes an image of each stage is presented in Figure 2. The success of the synthetic cell preparation process is dependent on the appropriate performance of each stage and effected by different parameters. The protocol should be adjusted to accommodate the production of a specific pro.......

Discussion

This protocol introduces a simple and affordable method for the production of large quantities of protein-producing synthetic cells. The yield of active cells is dependent on careful and accurate execution of the protocol with emphasis on several critical steps. In the lysate preparation section of this method, it is essential to reach the appropriate bacteria density before cell lysis to achieve a sufficient amount of proteins in the bacterial lysate. Second, the lysis process should be performed at 4 °C and the ly.......

Acknowledgements

This work was supported by ERC-STG-2015-680242.

The authors also acknowledge the support of the Technion Integrated Cancer Center (TICC); the Russell Berrie Nanotechnology Institute; the Lorry I. Lokey Interdisciplinary Center for Life Sciences & Engineering; the Israel Ministry of Economy for a Kamin Grant (52752); the Israel Ministry of Science Technology and Space – Office of the Chief Scientist (3-11878); the Israel Science Foundation (1778/13, 1421/17); the Israel Cancer Association (2015-0116); the German-Israeli Foundation for Scientific Research and Development for a GIF Young grant (I-2328-1139.10/2012); the European Unio....

Materials

NameCompanyCatalog NumberComments
A. Reagents required for step 1 (S30-T7 lysate preparation)
E.coli BL21 (DE3) NEBC2527E.coli BL21 (DE3).
pAR1219SigmaT2076TargeTron vector for transformation.
Stock solution of 50 mg/mL AmpicillinSigmaA9518Stored at -20 °C.
10 g/L Bacto-tryptoneBD Bioscience 211705For preparation of Luria Bertani (LB) agar (1.5%) plate.
10 g/L Sodium chloride (NaCl)Bio-Lab19030591
5 g/L Bacto-Yeast extractBD Bioscience 212750
15 g/L Agar agar purifiedMerck1.01614.5007
50 µg/mL AmpicillinSigmaA9518
10 g/L Bacto-tryptoneBD Bioscience 211705For preparation of Luria Bertani (LB) media (20 mL).
10 g/L Sodium chloride (NaCl)Bio-Lab19030591
5 g/L Bacto-Yeast extractBD Bioscience 212750
50 µg/mL AmpicillinSigmaA9518
12 g/L Bacto-tryptoneBD Bioscience 211705For preparation of Terrific Broth (TB) media (1 L).
24 g/L Bacto-Yeast extractBD Bioscience 212750
4% (v/v) Glycerol anhydrousBio-Lab7120501
2.32 g/L K2HPO4Spectrum chemicalP1383
12.54 g/L KH2PO4Spectrum chemicalP1380
 50 µg/mL AmpicillinSigmaA9518
Stock solution of 100 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) INALCOINA-1758-1400Filtered using 0.2 µm hydrophilic PVDF syringe filter.
Stock solution of 0.1 M dithiothreitol (DTT) TCID1071Filtered using 0.2 µm hydrophilic PVDF syringe filter.
10 mM Tris-acetate at pH = 7.4SigmaT1503S30 lysate buffer (1.5 L)
14 mM magnesium acetateMerck1.05819.0250
60 mM potassium acetateCarlo Erba470147
1 mM DTTTCID1071
0.5 mL/L 2-mercaptoethanolSigmaM6250
Equipment required for step 1
100 mL sterilized Erlenmeyer flasksThermo Scientific50-154-28462 flasks
2 L sterilized Erlenmeyer flasks with bafflesKIMAX-KIMBLE256302 flasks
Floor incubator shakerMRCTOU-120-2Laboratory shaker incubator 450x450mm, 400rpm, 70 °C
CentrifugeThermo Scientific75004270(75003340) - Fiberlite F10-6 x 100 LEX Fixed-Angle Rotor.
Should enable at least 13,000 x g.     * Pre-cooled to 4 °C.
High pressure homogenizerAVESTINEmulsiFlex-C3Pre-cooled to 4 °C.
-80oC freezerSO-LOWU85-18
Sterilized 1.5 mL plastic tubesEppendorf30120086Preferably pre-cooled to -20 °C.
SpectrophotometerTECANIN-MNANOInfinite M200 pro
96-well transparent plateThermo Scientific167008
Sterilized graduated cylinderCorning
Sterilized centrifuge tubesEppendorf30120086Preferably pre-cooled to -20 °C.
Sterilized pipette tipsCorningPreferably pre-cooled to -20 °C.
Crushed ice bucketBel-ArtM18848-4001
Small liquid nitrogen tankNALGENE4150-4000
B. Reagents required for step 3 (lipids in oil solution preparation):
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)Lipoid556400Powder
CholesterolSigmaC8667Powder
ChloroformBio-Lab3082301
Mineral oilSigmaM5904Light oil
Equipment required for step 2
Vortex mixerScientific industriesSI-0256
Heating blockTECHNEFDB03ADPre-heated to 80 °C.
Should enable controlled temperature. 
2 mL screw neck glass vialsCSI Analytical InnovationsVT009M-1232For a larger scale, use 50 mL falcons and evaporate the chloroform using rotary evaporator.
9mm Screw CapCSI Analytical InnovationsC395R-09LC
C. Reagents required for step 3 (inner and feeding reaction mixtures):
HEPESSpectrumH10891 M HEPES-KOH (pH = 8) - pH buffer
Potassium hydroxide (KOH)Frutarom55290
1 M Magnesium acetateMerck1.05819.0250Co-factor and negative charge stabilizor.
1 M Potassium acetateCarlo Erba470147Negative charge stabilizor.
5.2 M Ammonium acetateMerck1.01116.1000Stabilizes negative charge.
50% (w/v) Polyethylene glycol 6000 (PEG)Merck8.07491.1000Increases the concentration of the macromolecules.
0.5 M 3-phosphoglycerate (3-PGA)SigmaP8877Secondary energy source.
50 mM Amino acids mixture ISigmaLAA21-1KTAmino acids additive.
Contains: 50 mM of each of the following 17  natural amino acids - alanine, arginine, asparagine, aspartic acid, cysteine, glutamine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, proline, serine, threonine, and valine.
50 mM Amino acids mixture IISigmaLAA21-1KTAmino acids additive.
Contains: 50 mM of each of the following 3 natural amino acids - tryptophan, phenylalanine, and tyrosine.
100 mM Adenine triphosphate (ATP)SigmaA3377Nucleotides & energy source.
50 mM Guanidine triphosphate (GTP)SigmaG8877Nucleotides & energy source.
100 mM Uridine triphosphate (UTP)ACROS ORGANICS226310010Nucleotides additive.
100 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG)INALCOINA-1758-1400Genes expression induction.
2 M SucroseJ.T. Baker1933078Generating a density gradient.
2 M GlucoseSigma16301Generating a density gradient.
H2O UltraPure Water (UPW)Bio-Lab2321777500DNase & RNase free
S30-T7 lysate__Prepared at step 1.                                                                        Source of transcription & translation components.
Store at -80 °c, thaw on crashed ice just before usage. 
Stock of DNA plasmid of choice__Contains the sequence for the requested protein.
Under T7 promotor
D. Equipment required for step 4 (synthetic cells preparation)
Floor incubator shaker or ThermomixerMRCTOU-120-2Laboratory shaker incubator 450x450mm, 400rpm, 70 °C
PHMT Grant Bio PSC18Thermomixer
CentrifugeThermo Scientific75004270(75003629) - TX-400 4 x 400mL Swinging Bucket Rotor.
Suited for 15 mL sized tubes.
Preferably swinging buckets.
Should enable at least 1000 x g.
Pre-cooled to 4 °C.
Table centrifugeThermo Scientific75002420(75003424) - 24 x 1.5/2.0mL rotor with ClickSeal.
Suited for Eppendorf vials.
Pre-cooled to 4 °C.
Vortex mixerScientific industriesSI-0256
Crushed ice bucketBel-ArtM18848-4001
2 mL screw neck glass vialsCSI Analytical InnovationsVT009M-1232
Sterile 15 mL plastic tubesThermo Scientific339651
Sterilized 1.5 mL plastic tubesEppendorf30120086
Sterilized pipette tipsCorningSterilized by autoclave.

References

  1. Blain, J. C., Szostak, J. W. Progress toward synthetic cells. Annual review of biochemistry. 83, 615-640 (2014).
  2. Richmond, D. L., et al. Forming giant vesicles with controlled membrane composition, asymmetry, and contents.

Explore More Articles

AI based Protein ProductionCell free Bacterial ExtractsLiposome based Synthetic CellsEmulsion TransferIn situ Therapeutic Protein SynthesisMetabolic Disease TreatmentProtein Replacement TherapiesCancer TherapyDiabetes Treatment

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved